Krebs Biochemicals & Industries Share Price | Krebs Biochemicals & Industries Stock Screener
KREBSBIO
Pharmaceuticals
Share Price NSE
₹56.07
▲
0.91 (1.65%)
Share Price BSE
₹53.81
▼
-1.18 (-2.15%)
As of May 21, 2026, the Krebs Biochemicals & Industries share price (NSE: KREBSBIO) is ₹56.07 on NSE and ₹53.81 on BSE, up 1.65% from the previous close, with shares trading between ₹54.32 and ₹57.00, and a 52-week range of ₹39.75–₹80.70.
Check KREBSBIO yearly price range for the annual price range and momentum.
Use the Krebs Biochemicals & Industries stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Krebs Biochemicals & Industries Market Cap
₹120.95 Cr.
KREBSBIO P/E Ratio (TTM)
-5.34
Krebs Biochemicals & Industries P/B Ratio
-0.76
EPS (TTM)
₹-12.49
Dividend Yield
-
Debt to Equity
-
KREBSBIO 52 Week High
₹80.70
Krebs Biochemicals & Industries 52 Week Low
₹39.75
Operating Margin
-47.00%
Profit Margin
-100.00%
KREBSBIO Revenue (TTM)
₹23.00
EBITDA
₹-10.00
Net Income
₹-23.00
Total Assets
₹169.00
Total Equity
₹-146.00
Krebs Biochemicals & Industries Share Price Chart
Screen Krebs Biochemicals & Industries share price with an interactive chart. Analyse KREBSBIO price trends and volatility across different timeframes.
Krebs Biochemicals & Industries Company Profile - Fundamental Screener
Screen Krebs Biochemicals & Industries company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for KREBSBIO shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE268B01013
Krebs Biochemicals & Industries Balance Sheet Screener
Screen KREBSBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 169 | 178 | 175 | 190 | 159 | 134 | 142 | 126 | 122 | 116 |
| Current Assets | 10 | 17 | 16 | 36 | 21 | 19 | 31 | 17 | 13 | 9 |
| Fixed Assets | 146 | 150 | 147 | 139 | 118 | 105 | 101 | 101 | 102 | 93 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 212 | 236 | 225 | 187 | 154 | 116 | 102 | 101 | 89 | 74 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | -146 | -119 | -100 | -75 | -43 | -25 | -14 | -18 | 2 | 13 |
| Share Capital | 22 | 22 | 22 | 22 | 20 | 18 | 17 | 14 | 14 | 13 |
| Reserves & Surplus | -168 | -141 | -121 | -97 | -67 | -43 | -31 | -32 | -12 | -4 |
Krebs Biochemicals & Industries Income Statement Screener - Profit & Revenue Analysis
Screen Krebs Biochemicals & Industries income statement and profit fundamentals.
Analyze KREBSBIO quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Krebs Biochemicals & Industries share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23 | 44 | 51 | 53 | 61 | 54 | 34 | 48 | 34 | 3 | 2 | 0 |
| Expenses | 33 | 58 | 59 | 68 | 94 | 71 | 52 | 58 | 41 | 11 | 14 | 5 |
| EBITDA | -10 | -14 | -8 | -15 | -33 | -17 | -18 | -10 | -7 | -8 | -11 | -5 |
| Operating Profit % | -47.00% | -35.00% | -17.00% | -30.00% | -57.00% | -33.00% | -56.00% | -21.00% | -22.00% | -246.00% | -962.00% | 0.00% |
| Depreciation | 6 | 7 | 7 | 7 | 6 | 5 | 5 | 4 | 4 | 4 | 5 | 2 |
| Interest | 7 | 6 | 5 | 3 | 5 | 6 | 6 | 6 | 5 | 4 | 1 | 4 |
| Profit Before Tax | -23 | -27 | -20 | -25 | -45 | -28 | -29 | -20 | -18 | -16 | -16 | -8 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -23 | -27 | -20 | -25 | -45 | -28 | -29 | -20 | -18 | -16 | -16 | -8 |
| EPS | -10.60 | -12.49 | -9.15 | -11.30 | -20.81 | -14.37 | -17.90 | -12.83 | -12.97 | -11.68 | -12.49 | -8.24 |
Krebs Biochemicals & Industries Cash Flow Screener - Liquidity Fundamentals
Screen KREBSBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -8 | 2 | -25 | -17 | -15 | -36 | 4 | -6 | -11 | -15 |
| Investing Activities | -5 | -8 | -13 | -23 | -23 | -10 | -4 | -3 | -5 | -4 |
| Financing Activities | 13 | 6 | 37 | 40 | 38 | 29 | 17 | 9 | 16 | 13 |
| Net Cash Flow | 0 | 0 | 0 | -1 | 1 | -17 | 17 | 0 | 0 | -6 |
Krebs Biochemicals & Industries Shareholding Pattern Screener
See Krebs Biochemicals & Industries shareholding pattern with promoter, FII, and DII holdings.
Check Krebs Biochemicals & Industries promoter holding and ownership changes for KREBSBIO on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% | 72.74% |
| FII Holding | 0.50% | 0.50% | 0.50% | 0.50% | 0.00% | 0.50% | 0.50% | 0.50% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 19.81% | 20.42% | 19.73% | 19.70% | 19.80% | 20.11% | 19.97% | 19.80% |
| Other Holding | 6.95% | 6.34% | 7.03% | 7.06% | 7.46% | 6.65% | 6.79% | 6.96% |
| Shareholder Count | 8,553 | 8,798 | 9,118 | 8,912 | 8,710 | 8,909 | 8,848 | 9,425 |
Krebs Biochemicals & Industries Share Dividend Screener - Share Yield Analysis
Check Krebs Biochemicals & Industries dividend history with payout and yield data.
View Krebs Biochemicals & Industries dividend details including ex-dates and amounts for KREBSBIO stock.
Krebs Biochemicals & Industries Stock Index Membership
See which indices include Krebs Biochemicals & Industries stock.
Check KREBSBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Krebs Biochemicals & Industries Market Events Screener - Corporate Actions
Get Krebs Biochemicals & Industries corporate actions including splits, bonuses, and buybacks.
Check Krebs Biochemicals & Industries stock events that may affect KREBSBIO share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 1.42% | ||
| Annual General Meeting | NA | -0.22% | ||
| 2026-05-21 | 2026-05-21 | Quarterly Result Announcement | NA | -8.55% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | -9.09% |
| 2025-11-04 | 2025-11-04 | Quarterly Result Announcement | NA | -2.29% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -3.19% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 4.40% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | 15.40% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | 18.22% |
| 2019-01-31 | 2019-02-01 | Rights | 21:100 | -11.92% |
Krebs Biochemicals & Industries Competitors Screener - Peer Comparison
Screen KREBSBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 450,643 | 40.81 | 54,729 | 9.71% | 10,980 | 64.89 |
| Divis Laboratories | 179,470 | 74.13 | 9,712 | 18.67% | 2,191 | 64.06 |
| Torrent Pharmaceuticals | 149,109 | 65.68 | 11,539 | 6.99% | 1,911 | 58.52 |
| Cipla | 115,682 | 30.09 | 27,712 | -2.46% | 3,783 | 69.78 |
| Dr Reddys Laboratories | 111,567 | 26.16 | 33,593 | -0.44% | 3,998 | 59.87 |
| Lupin | 104,032 | 19.28 | 27,488 | 19.98% | 5,345 | 46.11 |
| Mankind Pharma | 103,325 | 56.36 | 12,744 | 20.90% | 2,007 | 73.37 |
| Zydus Life Science | 101,801 | 19.85 | 23,511 | 18.55% | 4,615 | 69.47 |
| Aurobindo Pharma | 87,806 | 25.16 | 32,346 | 9.43% | 3,484 | 73.83 |
| Laurus Labs | 71,455 | 79.78 | 6,813 | 21.03% | 884 | 80.26 |
Krebs Biochemicals & Industries Company Announcements - News Screener
Screen KREBSBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-13 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-04-10 | Clarification On Price Movement | - |
| 2026-04-08 | Clarification Sought from Krebs Biochemicals & Industries Ltd | - |
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-19 | Closure of Trading Window | - |
| 2026-02-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-09 | Results Quarter Ended 31.12.2025 | - |
| 2026-02-09 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-01-14 | Board Meeting Intimation for Board Meeting Intimation To Consider And Adopt The Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended December 31 2025 | - |
| 2026-01-05 | Report On Re-Lodgement Of Transfer Requests Of Physical Shares Dec 2025 | - |
| 2026-01-02 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-22 | Closure of Trading Window | - |
| 2025-12-03 | Report On Re-Lodgement Of Transfer Requests Of Physical Shares Nov 2025 | - |
| 2025-11-18 | Report On Re-Lodgement Of Transfer Requests Of Physical Shares Oct 2025 | - |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-04 | Result Sept 2025 | - |
| 2025-11-04 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2025-10-16 | Board Meeting Intimation for Board Meeting Intimation For The Quarter Ended 30.09.2025. | - |
| 2025-10-08 | Report On Re-Lodgement Of Transfer Requests Of Physical Shares | - |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |